ASTRAZENECA ORD SHS USD 0.25 overview

Hardman & Co Research Hardman & Co Research: AstraZeneca: Where has all the cash gone? 05-Jun-2019 / 12:36 GMT/BST Hardman & Co Research: AstraZeneca: Where has all the cash gone? Historically, AstraZeneca (AZN) was a leading global pharmaceutical company, but it has slipped down the rankings following a period of patent expiry on major drugs, notably Nexium, Losec and Seroquel. Understandably, the financial performance, particularly operational cashflow, has suffered through this period and AZN...

ProPhotonix Announces Results of AGM and Director / PDMR Shareholdings SALEM, NEW HAMPSHIRE / ACCESSWIRE / May 16, 2019 / ProPhotonix Limited (OTC: STKR and London Stock Exchange - AIM: PPIX), a high technology designer and manufacturer of LED illumination systems and laser diode modules, with operations in Ireland and the United Kingdom, announces that at its Annual General Meeting held today all matters put before the shareholders were duly passed. Under the director compensation policy, the...

Hardman & Co Research Hardman & Co Research: Global Pharmaceuticals: 2018 industry sales 09-Apr-2019 / 16:10 GMT/BST Hardman & Co Research: Global Pharmaceuticals: 2018 industry sales Over the last few weeks, most of the multi-national pharmaceutical companies have reported results for 2018, which has given us the opportunity to update our industry statistics and drug database. This report provides the first publication of global and US rankings of the top 15 drug companies for 2018. Comparisons...